230 related articles for article (PubMed ID: 34747055)
1. The Glucocorticoid Receptor in Osterix-Expressing Cells Regulates Bone Mass, Bone Marrow Adipose Tissue, and Systemic Metabolism in Female Mice During Aging.
Pierce JL; Sharma AK; Roberts RL; Yu K; Irsik DL; Choudhary V; Dorn JS; Bensreti H; Benson RD; Kaiser H; Khayrullin A; Davis C; Wehrle CJ; Johnson MH; Bollag WB; Hamrick MW; Shi X; Isales CM; McGee-Lawrence ME
J Bone Miner Res; 2022 Feb; 37(2):285-302. PubMed ID: 34747055
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of glucocorticoid receptor in bone marrow adipocytes has mild effects on bone and hematopoiesis but does not influence expansion of marrow adiposity with caloric restriction.
Schill RL; Visser J; Ashby ML; Li Z; Lewis KT; Morales-Hernandez A; Hoose KS; Maung JN; Uranga RM; Hariri H; Hermsmeyer IDK; Mori H; MacDougald OA
Front Endocrinol (Lausanne); 2024; 15():1397081. PubMed ID: 38887268
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Glucocorticoid Signaling in the Regulation of Bone and Marrow Adiposity: Lessons from Metabolism and Cross Talk in Other Tissues.
Sharma AK; Shi X; Isales CM; McGee-Lawrence ME
Curr Osteoporos Rep; 2019 Dec; 17(6):438-445. PubMed ID: 31749087
[TBL] [Abstract][Full Text] [Related]
4. Phosphate restriction impairs mTORC1 signaling leading to increased bone marrow adipose tissue and decreased bone in growing mice.
Ko FC; Kobelski MM; Zhang W; Grenga GM; Martins JS; Demay MB
J Bone Miner Res; 2021 Aug; 36(8):1510-1520. PubMed ID: 33900666
[TBL] [Abstract][Full Text] [Related]
5. The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat.
Pierce JL; Ding KH; Xu J; Sharma AK; Yu K; Del Mazo Arbona N; Rodriguez-Santos Z; Bernard P; Bollag WB; Johnson MH; Hamrick MW; Begun DL; Shi XM; Isales CM; McGee-Lawrence ME
J Endocrinol; 2019 Jul; ():. PubMed ID: 31370004
[TBL] [Abstract][Full Text] [Related]
6. Update on the Role of Glucocorticoid Signaling in Osteoblasts and Bone Marrow Adipocytes During Aging.
Bensreti H; Alhamad DW; Gonzalez AM; Pizarro-Mondesir M; Bollag WB; Isales CM; McGee-Lawrence ME
Curr Osteoporos Rep; 2023 Feb; 21(1):32-44. PubMed ID: 36564571
[TBL] [Abstract][Full Text] [Related]
7. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
[TBL] [Abstract][Full Text] [Related]
8. A miR-29a-driven negative feedback loop regulates peripheral glucocorticoid receptor signaling.
Glantschnig C; Koenen M; Gil-Lozano M; Karbiener M; Pickrahn I; Williams-Dautovich J; Patel R; Cummins CL; Giroud M; Hartleben G; Vogl E; Blüher M; Tuckermann J; Uhlenhaut H; Herzig S; Scheideler M
FASEB J; 2019 May; 33(5):5924-5941. PubMed ID: 30742779
[TBL] [Abstract][Full Text] [Related]
9. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
10. Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice.
Henneicke H; Kim S; Swarbrick MM; Li J; Gasparini SJ; Thai J; Foong D; Cavanagh LL; Fong-Yee C; Karsten E; Lin RCY; Cooper MS; Zhou H; Seibel MJ
Mol Metab; 2020 Dec; 42():101098. PubMed ID: 33045434
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of depression-like behavior to glucocorticoids and antidepressants is independent of forebrain glucocorticoid receptors.
Vincent MY; Hussain RJ; Zampi ME; Sheeran K; Solomon MB; Herman JP; Khan A; Jacobson L
Brain Res; 2013 Aug; 1525():1-15. PubMed ID: 23727405
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.
Le PT; Bishop KA; Maridas DE; Motyl KJ; Brooks DJ; Nagano K; Baron R; Bouxsein ML; Rosen CJ
Bone; 2017 Dec; 105():103-114. PubMed ID: 28821457
[TBL] [Abstract][Full Text] [Related]
13. Loss of epidermal glucocorticoid receptor protects against whole body metabolic dysfunction upon chronic corticosterone treatment.
Gallego A; Pérez P
Mol Metab; 2023 Aug; 74():101763. PubMed ID: 37364709
[TBL] [Abstract][Full Text] [Related]
14. Deletion of Hsd11b1 suppresses caloric-restriction-induced bone marrow adiposity in male but not female mice.
Lovdel A; Suchacki K; Roberts F; Sulston RJ; Wallace RJ; Thomas BJ; Bell RMB; Pruñonosa Cervera I; Macpherson G; Morton N; Homer NZZM; Chapman KE; Cawthorn WP
J Endocrinol; 2024 May; ():. PubMed ID: 38805506
[TBL] [Abstract][Full Text] [Related]
15. Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor Cells.
McGee-Lawrence ME; Carpio LR; Schulze RJ; Pierce JL; McNiven MA; Farr JN; Khosla S; Oursler MJ; Westendorf JJ
J Bone Miner Res; 2016 Jan; 31(1):116-28. PubMed ID: 26211746
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo.
Hildebrandt S; Baschant U; Thiele S; Tuckermann J; Hofbauer LC; Rauner M
Sci Rep; 2018 Jun; 8(1):8711. PubMed ID: 29880826
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Glucocorticoid Receptor Plays a Greater Role Than Adipose GR in Metabolic Syndrome Despite Renal Compensation.
Bose SK; Hutson I; Harris CA
Endocrinology; 2016 Dec; 157(12):4943-4960. PubMed ID: 27754788
[TBL] [Abstract][Full Text] [Related]
18. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.
Zhu W; Liang G; Huang Z; Doty SB; Boskey AL
J Biol Chem; 2011 Jul; 286(30):26794-805. PubMed ID: 21636574
[TBL] [Abstract][Full Text] [Related]
19. Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis.
Campbell JE; Fediuc S; Hawke TJ; Riddell MC
Metabolism; 2009 May; 58(5):651-60. PubMed ID: 19375588
[TBL] [Abstract][Full Text] [Related]
20. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U
Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
